Researcher
Rein Verbeke
- Disciplines:Other pharmaceutical sciences, Pharmacognosy, Pharmogenetics and -genomics, Pharmacotherapy, Biomarker discovery, Clinical trials, Toxicogenomics, Biopharmaceuticals, Biopharmaceutics
Affiliations
- Department of Pharmaceutics (Department)
Member
From16 Sep 2013 → Today
Projects
1 - 4 of 4
- LNP-DECODE: Deciphering the adjuvants activity of lipid nanoparticle-based mRNA vaccines in primary dendritic cellsFrom1 Jan 2024 → TodayFunding: BOF - projects
- Exploration of an mRNA based nanovaccine platform and immunopeptidomics for the development of more effective tuberculosis vaccines.From1 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Understanding and modulating the pro-inflammatory activity of lipid nanoparticles (LNP) in the COVID-19 mRNA vaccines: towards the development of more effective LNP formulations.From1 Oct 2022 → TodayFunding: FWO senior postdoctoral fellowship
- mRNA Lipid nanoparticles co-loaded with alpha-Galactosylceramide as a universal influenza vaccine platformFrom1 Oct 2020 → 30 Sep 2022Funding: BOF - postdoctoral mandates
Publications
11 - 20 of 27
- Covipendium : information available to support the development of medical countermeasures and interventions against COVID-19(2021)
Authors: Martine Denis, Valerie Vandeweerd, Rein Verbeke, Anne Laudisoit, Tristan Reid, Emma Hobbs, Laure Wynants, Diane Van der Vliet
Pages: 1 - 296 - mRNA in cancer immunotherapy : beyond a source of antigen(2021)
Authors: Lien Van Hoecke, Rein Verbeke, Heleen Dewitte, Ine Lentacker, Karim Vermaelen, Karine Breckpot, Sandra Van Lint
- mRNA encoding a bispecific single domain antibody construct protects against influenza A virus infection in mice(2020)
Authors: Lien Van Hoecke, Rein Verbeke, Dorien De Vlieger, Heleen Dewitte, Sharon Van Nevel, Claus Bachert, Ine Lentacker
Pages: 777 - 787 - Intracellular delivery of mRNA in adherent and suspension cells by vapor nanobubble photoporation(2020)
Authors: Laurens Raes, Stephan Stremersch, Juan Fraire, Toon Brans, Glenn Goetgeluk, Stijn De Munter, Lien Van Hoecke, Rein Verbeke, Jelter Van Hoeck, Ranhua Xiong, et al.
- Three decades of messenger RNA vaccine development(2019)
Authors: Rein Verbeke, Ine Lentacker, Stefaan De Smedt, Heleen Dewitte
- Broadening the message : a nanovaccine co-loaded with messenger RNA and α-GalCer induces antitumor immunity through conventional and natural killer T cells(2019)
Authors: Rein Verbeke, Ine Lentacker, Karine Breckpot, Jonas Janssens, Serge Van Calenbergh, Stefaan De Smedt, Heleen Dewitte
Pages: 1655 - 1669 - Challenges for labeling and longitudinal tracking of adoptively transferred autoreactive T lymphocytes in an experimental type-1 diabetes model(2019)
Authors: Shweta Saini, Hannelie Korf, Sayuan Liang, Rein Verbeke, Bella Manshian, Koen Raemdonck, Ine Lentacker, Conny Gysemans, Uwe Himmelreich
Pages: 295 - 305 - Design of messenger RNA lipid nanoparticles for cancer immunotherapy(2019)
Authors: Rein Verbeke
- Longitudinal in vivo assessment of host-microbe interactions in a murine model of pulmonary aspergillosis(2019)
Authors: Shweta Saini, Jennifer Poelmans, Hannelie Korf, James L. Dooley, Sayuan Liang, Bella B. Manshian, Rein Verbeke, Stefaan J. Soenen, Greetje Vande Velde, Ine Lentacker, et al.
Pages: 184 - 194 - Optimized messenger RNA immunolipoplexes for cancer immunotherapy : balancing immunogenicity and adjuvancy(2018)
Authors: Rein Verbeke, Ine Lentacker, Karine Breckpot, Heleen Dewitte
Number of pages: 1
Patents
1 - 2 of 2